Korean J Nephrol.
2009 May;28(3):211-218.
Leflunomide Treatment in BK Virus Associated Nephropathy after Renal Transplantation
- Affiliations
-
- 1Department of Internal Medicine, Bong Seng Hospital, Busan, Korea. kidney119@hotmail.com
- 2Department of Pathology, Yonsei University, Korea.
Abstract
-
PURPOSE:BK virus associated nephropathy (BKVAN) affects 1-10% of kidney transplant (KT) patients and it produces a progressive destruction of allograft. Reducing immunosuppression is the only way to save the graft, while it needs tight monitoring of the graft rejection and graft survival is poorer in advanced case. Leflunomide has immunosuppressive effect and also antiviral activity. Addition of leflunomide may improve BK virus clearance and graft survival.
METHODS
6 KT patients with biopsy proven BKVAN (Histological pattern B) were treated with leflunomide and reduced immunosuppression. All patients were monitored with serial determination of viral load in blood and graft function.
RESULTS
BKVAN was diagnosed at 14 months (7-28) post transplant, at that time median serum creatinine concentration was 2.8 mg/dL (1.8-3.6). 12.5 months (6-16) later of leflunomide treatment, median serum creatinine was 2.3 mg/dL and no graft loss was found.
CONCLUSION
Leflunomide therapy with reduced immunosuppression may be effective in the treatment for BKVAN.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Combining Intravenous Immunoglobulin and Leflunomide for BK Nephropathy
- Treatment of Presumptive BK Nephropathy with Ciprofloxain in Kidney Transplant Recipients: Three Case Reports
- A Case of BK Virus Nephropathy with Strong C4d Deposition in a Renal Allograft Recipient
- Combination therapy of low-dose cidofovir and leflunomide in a kidney transplant recipient with BK virus nephropathy: a case report
- BK Virus Detection by Polymerase Chain Reaction in Renal Transplant Recipients and Healthy Donors
